Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.16% |
| 2 | Technology | 2.2% |
| 3 | Consumer Discretionary | 1.94% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Anika Therapeutics
ANIK
$282M
| $2.16M | ﹤0.01% |
41,720
-8,864
| -18% | -$515K |
|
|
DRNA
4152
PUT
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.16M | ﹤0.01% |
+98,200
| New | +$1.98M |
|
|
LEG
4153
DELISTED
Leggett & Platt
LEG
| $2.16M | ﹤0.01% |
42,517
+28,291
| +199% | +$1.39M |
|
4154
PUT
Clarivate
CLVT
$1.29B
| $2.16M | ﹤0.01% |
+128,600
| New | +$2.17M |
|
4155
CALL
National Vision
EYE
$1.37B
| $2.16M | ﹤0.01% |
66,600
-32,500
| -33% | -$894K |
|
|
CRC
4156
DELISTED
California Resources Corporation
CRC
| $2.16M | ﹤0.01% |
238,885
-313,870
| -57% | -$2.54M |
|
4157
PUT
MidCap Financial Investment
MFIC
$792M
| $2.16M | ﹤0.01% |
123,500
-32,600
| -21% | -$538K |
|
|
AVP
4158
PUT
DELISTED
Avon Products, Inc.
AVP
| $2.16M | ﹤0.01% |
382,300
-146,300
| -28% | -$680K |
|
4159
McEwen Inc
MUX
$1.25B
| $2.15M | ﹤0.01% |
169,661
+3,822
| +2% | +$54K |
|
4160
PUT
Direxion Daily Energy Bear 2X ETF
ERY
$39.8M
| $2.15M | ﹤0.01% |
5,480
+1,920
| +54% | +$895K |
|
|
DHC
4161
Diversified Healthcare Trust
DHC
$1.85B
| $2.15M | ﹤0.01% |
254,882
+17,307
| +7% | +$146K |
|
4162
Invesco S&P 500 Revenue ETF
RWL
$9.98B
| $2.15M | ﹤0.01% |
36,863
+32,639
| +773% | +$1.83M |
|
4163
CALL
AGCO
AGCO
$7.94B
| $2.15M | ﹤0.01% |
27,800
+4,600
| +20% | +$353K |
|
|
PENG
4164
CALL
Penguin Solutions Inc
PENG
$2.54B
| $2.15M | ﹤0.01% |
113,200
-98,800
| -47% | -$1.53M |
|
|
RAVN
4165
CALL
DELISTED
Raven Industries Inc
RAVN
| $2.15M | ﹤0.01% |
62,300
+22,500
| +57% | +$768K |
|
4166
PUT
Harrow
HROW
$1.4B
| $2.15M | ﹤0.01% |
275,700
-140,700
| -34% | -$815K |
|
4167
PUT
Regency Centers
REG
$13.8B
| $2.15M | ﹤0.01% |
+34,000
| New | +$2.23M |
|
4168
Liberty Media Series A
FWONA
$23.4B
| $2.14M | ﹤0.01% |
51,142
+14,569
| +40% | +$572K |
|
4169
Smith Micro Software
SMSI
$16.3M
| $2.14M | ﹤0.01% |
+13,466
| New | +$2.66M |
|
4170
CALL
AnaptysBio
ANAB
$1.67B
| $2.14M | ﹤0.01% |
131,900
+80,700
| +158% | +$1.91M |
|
|
AXON
4171
Axon Enterprise
AXON
$48.8B
| $2.14M | ﹤0.01% |
29,192
-19,198
| -40% | -$1.21M |
|
4172
CALL
Werner Enterprises
WERN
$2.3B
| $2.14M | ﹤0.01% |
58,700
-24,500
| -29% | -$896K |
|
4173
Schwab Emerging Markets Equity ETF
SCHE
$13B
| $2.13M | ﹤0.01% |
+77,978
| New | +$2.06M |
|
|
WCC
4174
PUT
WESCO International
WCC
$16.4B
| $2.13M | ﹤0.01% |
35,900
+24,700
| +221% | +$1.29M |
|
4175
VictoryShares US 500 Volatility Wtd ETF
CFA
$547M
| $2.13M | ﹤0.01% |
37,775
+30,074
| +391% | +$1.63M |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2019 filing shows 1,232 new, 3,827 increased, 4,449 reduced and 1,709 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M. The largest sale was Amazon, an estimated $1.36B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.